Literature DB >> 3131046

The effect of renal failure and haemodialysis on the concentration of free apolipoprotein A-1 in serum and the implications for the catabolism of high-density lipoproteins.

R H Neary1, E Gowland.   

Abstract

Free apolipoprotein A-1 (free A-1) was measured by quantitative crossed immunoelectrophoresis in 43 patients with severe chronic renal failure. The free A-1 concentrations in these patients were higher than in 28 healthy subjects irrespective of whether they where receiving haemodialysis or conservative treatment. A close correlation was found between serum concentration of free A-1 and creatinine in patients with varying degrees of chronic renal failure (r = 0.717, p less than 0.001). In three patients who received renal transplants serial measurements of free A-1 showed a decrease to normal levels within two days post-operatively. These findings suggest a relationship between the serum concentration of free A-1 and glomerular filtration. In conjunction with the report implicating the kidney as the major site of catabolism of Apo A-1 in the rat, these results suggest a similar role for the kidney in man. No evidence has been found linking free A-1 with hypertriglyceridaemia in patients with renal failure as has been suggested previously.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3131046     DOI: 10.1016/0009-8981(88)90149-0

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

1.  Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys.

Authors:  I J Goldberg; W S Blaner; T M Vanni; M Moukides; R Ramakrishnan
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

2.  Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol.

Authors:  B S Horowitz; I J Goldberg; J Merab; T M Vanni; R Ramakrishnan; H N Ginsberg
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

Review 3.  Lipoprotein metabolism in chronic renal insufficiency.

Authors:  Jeffrey M Saland; Henry N Ginsberg
Journal:  Pediatr Nephrol       Date:  2007-03-28       Impact factor: 3.714

4.  HDL functionality and cardiovascular outcome among nondialysis chronic kidney disease patients.

Authors:  Kathrin Untersteller; Sabine Meissl; Markus Trieb; Insa E Emrich; Adam M Zawada; Michael Holzer; Eva Knuplez; Danilo Fliser; Gunnar H Heine; Gunther Marsche
Journal:  J Lipid Res       Date:  2018-05-22       Impact factor: 5.922

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.